Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Regeneron Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 14, 2024 | Regeneron Pharmaceuticals Inc. | Option exercise | +1,535 | $625.60 | $960,296 |
| Jun 14, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,535 | $1,040.00 | $1,596,400 |
| May 28, 2024 | Regeneron Pharmaceuticals Inc. | Option exercise | +1,172 | $625.60 | $733,203 |
| May 28, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,172 | $974.86 | $1,142,536 |
| Jan 2, 2024 | Regeneron Pharmaceuticals Inc. | Grant or award | +135 | — | — |
| Dec 27, 2023 | Regeneron Pharmaceuticals Inc. | Option exercise | +2,049 | $482.68 | $989,011 |
| Dec 27, 2023 | Regeneron Pharmaceuticals Inc. | Open-market sale | −2,049 | $898.00 | $1,840,002 |
| Apr 21, 2023 | Regeneron Pharmaceuticals Inc. | Option exercise | +3,070 | $520.01 | $1,596,431 |
| Apr 21, 2023 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3,070 | $798.42 | $2,451,149 |
| Feb 6, 2023 | Regeneron Pharmaceuticals Inc. | Option exercise | +3,071 | $520.01 | $1,596,951 |
| Feb 6, 2023 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3,071 | $798.00 | $2,450,658 |
| Feb 6, 2023 | Regeneron Pharmaceuticals Inc. | Open-market sale | −500 | $797.00 | $398,500 |
| Jan 27, 2023 | Regeneron Pharmaceuticals Inc. | Option exercise | +1 | $520.01 | $520 |
| Jan 27, 2023 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1 | $747.00 | $747 |
| Jan 6, 2023 | Regeneron Pharmaceuticals Inc. | Option exercise | +3,070 | $520.01 | $1,596,431 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.